Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
13 December 2019 | Story Valentino Ndaba | Photo Johan Roux
Dr Thandi
After nearly seven years Dr Lewin finally graduates with a PhD.

Dr Thandi Lewin has spent the past six-and-a-half years of her life on her PhD.  It was only in the final year of the process that the thesis came together. “I had a few chapters and had done literature reviews and some theoretical work, as well as a little initial analysis, but none of it actually added up to a coherent thesis. The moment when I realised that I actually did have a thesis was a great feeling and a huge relief because it was only then that the end was in sight,” she said. 

On Wednesday 11 December 2019 her diligence culminated in a graduation ceremony at which she obtained her PhD in Higher Education Studies in the Faculty of Education at the University of the Free State (UFS). Dr Lewin formed a part of the pioneering cohort of the South African Research Chairs Initiative (SARChI) Chair in Higher Education and Human Development Research Programme, under the leadership of Professor Melanie Walker

Through the twists and turns

Working on her thesis on Early career women academics: A case study of working lives in a gendered institution, Dr Lewin struggled with time constraints. “I could not work on it every night or every early morning like some people do. My job was demanding, so I worked most nights and often went to bed quite late. Hence, I failed to focus on it during the week,” she explained.

When she began her PhD her youngest child was one year old. In addition to her job becoming more and more challenging over the years, Dr Lewin also had to maintain a morning and evening routine in order to make the most of the limited time she and her family had together. Yet after all was said and done, her research still beckoned.

Reaching the stage of walking across the stage

Given the rigorous process of completing a PhD, one of the major motivators was her supervisor. “Prof Walker was loyal and never gave up on me. She was also pragmatic and understanding. The commitment from a supervisor who is considerate of your personal circumstances, but is also as dedicated to your research project as you are, is quite something to find.”

For much of the past three years of her doctorate, Dr Lewin’s father was ill. He eventually succumbed to his illness in January 2019. The graduate struggled with managing her emotions as she felt guilty about not spending enough time with him due to work and research. “Being a mum and a daughter meant that if I wasn’t at work or working on my PhD I was with my kids or with my dad. But I must also acknowledge that my partner, nanny, and part-time housekeeper provided critical support which I couldn’t have done without.”

On gender and organisational cultures

The Chief Director for Institutional Governance and Management support in the university education branch of the Department of Higher Education and Training found the experience garnered in the system-level of higher learning enormously helpful in her research process.   “I have really enjoyed working in an area that interests me, and engaging with a topic that is policy-relevant,” she said.

Content
Melanie Walker (right) reading the PhD appraisal for Dr Thandi Lewin at the Graduation Ceremony.
(Photo: Johan Roux)


Cultivating culture change

Enabling women to rise through the ranks would require more effort to improve gender equity. “Organisations and universities can never really achieve gender equity without fundamentally changing their structures and cultures, which are deeply gendered. This also cannot happen without social change, which needs to take place in broader society and not only within organisations,” said Dr Lewin.

What this means for society and organisations is a shift from focusing solely on individual women. According to Dr Lewin: “Universities, in addition to their inclination towards slow change, are also experienced by many as exclusionary – not just by women, but by people of colour and those from working-class backgrounds, and others who have been traditionally marginalised in higher education. This is a critical issue for South African higher education – it is going to take a lot of time and focused commitment to change the cultures of universities to be more inclusive.”

News Archive

Link between champagne bubbles and the UFS?
2012-11-16

Prof. Lodewyk Kock with an example of a front page of the publication FEMS Yeast Research, as adapted by F. Belliard, FEMS Central Office.
Photo: Leatitia Pienaar
15 November 2012

What is the link between the bubbles in champagne and breakthrough research being done at the Mayo Clinic in America? Nano research being done at our university.

Prof. Lodewyk Kock of Biotechnology says a human being consists of millions of minute cells that are invisible to the eye. The nano technology team at the UFS have developed a technique that allows researchers to look into such a cell, as well as other microorganisms. In this way, they can get an idea of what the cell’s “insides” look like.

The UFS team – consisting of Profs. Kock, Hendrik Swart (Physics), Pieter van Wyk (Centre for Microscopy), as well as Dr Chantel Swart (Biotechnology), Dr Carlien Pohl (Biotechnology) and Liza Coetsee (Physics) – were amazed to see that the inside of cells consist of a maze of small tunnels or blisters. Each tunnel is about 100 and more nanometres in diameter – about one ten thousandth of a millimetre – that weaves through the cells in a maze.

It was also found that these tunnels are the “lungs” of the cells. Academics doing research on yeast have had to sit up and take notice of the research being done at the UFS – to the extent that these “lungs” will appear on the front page of the highly acclaimed FEMS Yeast Research for all of 2013.

The Mayo Clinic, in particular, now wants to work with the UFS to study cancer cells in more detail in order to fight this disease, says Prof. Kock. The National Cancer Institute of America has also shown interest. This new nano technology for biology can assist in the study and development of nano medicine that can be used in the treatment of cancer and other life threatening diseases. Nano medicine uses nano metal participles that are up to one billionth of a metre in size.

Prof. Kock says laboratory tests indicate that nano medicine can improve the efficacy of anti-cancer medicine, which makes the treatment less toxic. “According to the Mayo Clinic team, nano particles are considered as a gold cartridge which is being fired directly at a cancer tumour. This is compared to fine shot that spreads through the body and also attacks healthy cells.”

“This accuracy implies that the chemotherapy dose can be lowered with fewer side effects. The Mayo Clinic found that one-tenth of the normal dosage is more effective against pancreas cancer in this way than the full dosage with a linkage to nano particles. According to the clinic, this nano medicine could also delay the spread of cancer,” says Prof. Kock.

The nano particles are used as messengers that convey anti-cancer treatment to cancer cells, where it then selectively kills the cancer cells. The transport and transfer of these medicines with regard to gold nano particles can be traced with the UFS’s nano technology to collect more information, especially where it works on the cell.

“With the new nano technology of the UFS, it is possible to do nano surgery on the cells by slicing the cells in nanometre thin slices while the working of the nano medicine is studied. In this way, it can be established if the nano medicine penetrates the cells or if it is only associated with the tiny tunnels,” says Prof. Kock.

And in champagne the small “lungs” are responsible for the bubbles. The same applies to beer and with this discovery a whole new reach field opens for scientists.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept